Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help delay skin damage in lupus patients.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

A woman with severe hair loss was successfully treated with the drug adalimumab.

UV radiation causes skin cancer, but sunscreens and certain drugs can help prevent it.

Methotrexate can help some kids with severe hair loss regrow hair.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Linagliptin may cause hair loss and skin blisters.

Common skin conditions can greatly affect a person's mental health and social life.